Heron Therapeutics | HRTX - Trade Debtors


Heron Therapeutics reported $89.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
ALKERMES USD 407.63M 73.6M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amarin USD 126.83M 477K Dec/2025
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 178.55M 37.7M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 11.78B 345M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 125.64M 1.57M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Veracyte USD 50.11M 5.45M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026